Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Enteroendocrine hormone secretion modulation" refers to the regulation of hormone release from enteroendocrine cells (EECs), specialized cells located throughout the gastrointestinal tract and pancreas[3][7]. EECs secrete a wide variety of peptide hormones (such as GLP-1, GIP, CCK, and PYY) in response to luminal nutrients and other stimuli[4][3][2], thereby regulating processes such as appetite, digestion, metabolic homeostasis, and glucose metabolism[4]. The modulation of their hormone secretion can be achieved by targeting the various sensory receptors, ion channels, and intracellular signaling pathways expressed in these cells[1][6], but \"modulation\" itself is not a molecular target. Because this term refers to a process or mechanism, not a single molecule, receptor, or enzyme, it should not be used as a canonical therapeutic target. Specific pharmacological targets relevant to this process would be individual hormones (e.g., \"Glucagon-like peptide 1 receptor\"), their respective receptors, or specific EEC-expressed channels/GPCRs (e.g., GPR40, Piezo2)[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enteroendocrine hormone secretion modulation.